麻豆官网首页入口

Treatment for a local man with a rare cancer has been getting less effective. So John's oncologist asked for a new drug. It's called Osimertinib. His family believe it could extend his life expectancy with minimal side effects and a good quality of life. But - despite the fact that the National Institute for Health and Care Excellence has recommended it for use in England - it's not being made available for him, in Northern Ireland.